Meet The Cannabis Industry’s Trump Whisperer

Key Concepts

Rescheduling: The process of moving marijuana from Schedule I (high potential for abuse, no accepted medical use) to Schedule III (lower potential for abuse, accepted medical use) under the Controlled Substances Act.
Cannabis 42.0 List: An annual Forbes list recognizing entrepreneurs and innovators in the state-regulated cannabis industry.
Trulieve: A major U.S. cannabis corporation based in Florida, led by CEO Kim Rivers.
Lobbying: The act of influencing political decisions; in this case, persuading the Trump administration to reform federal cannabis policy.
Federal Headwinds: Legal and regulatory challenges posed by the federal government against the state-regulated cannabis industry.

The Rescheduling of Marijuana

On December 18, 2025, President Donald Trump signed an executive order directing then-Attorney General Pam Bondi to initiate the rescheduling of marijuana. This move aims to reclassify the drug from Schedule I—the same category as heroin and LSD—to Schedule III, alongside substances like ketamine and steroids. This represents the most significant federal drug reform since the inception of the "War on Drugs" in 1970.

Kim Rivers: The "Trump Whisperer"

Kim Rivers, CEO and Chairman of Trulieve, is credited as a primary architect of this policy shift. Over a two-year period, Rivers, alongside Boston financier Howard Kessler and other industry leaders, conducted a high-level lobbying campaign.

Strategy: Rivers utilized her status as a successful CEO and well-connected Floridian to gain access to the Oval Office.
Advocacy: She engaged in direct debates with opponents of reform, such as House Speaker Mike Johnson, arguing for the necessity of regulation and medical research.
Political Engagement: Trulieve and Rivers provided significant financial support to Trump-related political groups and the inaugural committee, including a $750,000 donation.

Trulieve’s Growth and Market Impact

Trulieve has evolved from a single dispensary in 2016 to a dominant industry player.

Founding: Formed in 2015 as a consortium involving nursery owners and business partners, the company secured one of the first five medical marijuana licenses in Florida.
Scale: As of 2025, the company operates nearly 239 stores across eight states.
Market Dominance: Trulieve holds a 35% market share in Florida’s medical cannabis market.
Financials: The company generated $1.2 billion in sales in 2024. A major milestone in its expansion was the 2021 acquisition of Arizona-based Harvest Health for $1.4 billion.
Leadership: Kim Rivers owns approximately 10% of the company’s stock, valued at over $100 million.

Methodology of Success

Rivers’ approach to building the company and influencing policy involved:

Strategic Partnerships: Leveraging connections with local nursery owners to navigate Florida’s initial licensing requirements.
Infrastructure Investment: Converting existing agricultural facilities (e.g., a tomato packing plant) into large-scale cultivation centers.
Public Markets: Taking the company public in Canada to raise capital for expansion.
Direct Advocacy: Moving beyond traditional lobbying to engage directly with the executive branch, framing cannabis reform as a benefit to the American people.

Notable Quotes

Kim Rivers on the President’s decision: "The president came to this decision on his own."
Rivers on the President’s motivation: "He believes it's the best thing for the American people, period."

Conclusion

The rescheduling of marijuana marks a pivotal shift in U.S. drug policy, moving the industry toward federal legitimacy. Kim Rivers’ role as the "Trump whisperer" highlights the power of targeted, high-level lobbying and corporate success in overcoming long-standing federal barriers. By successfully navigating both the regulatory landscape of Florida and the political environment of the White House, Rivers has positioned Trulieve as a leader in an industry that now spans 40 states with medical markets and 25 with recreational markets.